Project Grant HT94252410627
Award Date
9/30/24
Completion Date
9/29/28
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
The federal Project Grant award of $2,000,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research focused on investigating the interrelationship between the PINK1-PRKN pathway disruption and tauopathy in the pathophysiology of cognitive impairment in Parkinson's disease. The award, which has a performance period from June 1, 2025 to May 31, 2028, was granted to the Board of Regents...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
The federal Project Grant award for $200,000.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at Northwestern University to elucidate the neural basis of hallucinations in Parkinson's disease. The project will be conducted from July 1, 2025 to June 30, 2027. As a leading academic research institution, Northwestern University has a strong track record of securing federal grants and conducting cutting-edge...
This $655,380.00 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research to investigate maladaptive 5-HT raphe-corticolimbic plasticity underlying the development of nonmotor symptoms in Parkinson's disease. The award was made on September 30, 2024 to Dignity Health, a large non-profit healthcare organization, for a project that will be completed by September 29, 2028. Dignity Health, through its St....
This federal Project Grant award, with an ID of HT94252410926, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The $293,978 award will support a 2-year research project at the University of Illinois to investigate the relationship between cognition, vascular function, and physical activity in individuals with multiple sclerosis. The research aims to transform healthcare for military service members and the general...
This federal Project Grant award in the amount of $811,942 was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the J. David Gladstone Institutes, a non-profit biomedical research organization, to investigate genetic factors conferring susceptibility to toxicant-induced Parkinson's disease. The research involves a sub-award to the Northern California Institute For Research And...
This federal Project Grant award, valued at $673,448.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research on "MALADAPTIVE 5-HT RAPHE-CORTICOLIMBIC PLASTICITY UNDERLYING THE DEVELOPMENT OF NONMOTOR SYMPTOMS IN PARKINSON'S DISEASE" conducted by the awardee, The Research Foundation for the State University of New York (RF SUNY). The research aims to investigate the neural mechanisms underlying...
This federal Project Grant award of $649,762 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support research on maladaptive 5-HT raphe-corticolimbic plasticity and its role in the development of non-motor symptoms in Parkinson's disease. The award was granted to Dignity Health, a non-profit healthcare organization, with a performance period from September 30, 2024 to September 29, 2028. The research will be conducted through...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,493,233 to The Trustees of Columbia University in the City of New York to fund research on gene therapy in a nonhuman primate model of cognitive defects in Parkinson's disease. The award commenced on November 15, 2024 and is set to be completed by November 14, 2027. The university's Health Sciences Division will leverage its...
This federal Project Grant award, valued at $968,717.00, was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant was awarded to the University of Melbourne, a prominent Australian research institution, to conduct research aimed at solving a major complication of Parkinson's disease: debilitating constipation. The research project, with a performance period from April 15, 2025 to April 14, 2028, will focus on developing novel...